Nasal Cancer Treatment in Hyderabad — Expert Oncology Care Across 7 Locations

Why Nasal Cancer Is Often Diagnosed Late — And What to Watch For

Nasal and sinus cancer has one serious disadvantage: its early symptoms look almost exactly like a chronic sinus infection. Persistent nasal blockage, a runny nose that won't clear up, and occasional nosebleeds are easy to dismiss as sinusitis or allergies — and many patients are treated for these conditions for months before cancer is identified.

The warning signs that should prompt specialist evaluation — ideally an ENT or oncology review with nasal endoscopy and imaging — are:

• Nasal blockage or stuffiness on just one side — sinusitis usually affects both sides; one-sided symptoms are more concerning.
• Nosebleeds that recur without an obvious cause.
• Facial pain, pressure, or numbness — particularly in one cheek or around one eye.
• Swelling around the eye or cheek that wasn't there before.
• Changes in vision, or double vision — a sign the tumour may be pressing on orbital structures.
• Loose upper teeth or pain in the upper jaw without a dental cause.
• A lump in the neck — may indicate lymph node involvement.

If you have been treated for a sinus infection that keeps coming back without fully clearing, or if any of the above signs are present for more than 4–6 weeks, ask your doctor for a nasal endoscopy. Early diagnosis is the most important factor in nasal cancer outcomes.

Nasal Cancer vs Nasopharyngeal Cancer — An Important Distinction

Many patients and families confuse nasal cavity cancer with nasopharyngeal cancer (NPC) — and the two are quite different diseases. Nasopharyngeal cancer develops in the nasopharynx — the upper throat, directly behind the nose. It is associated with Epstein-Barr virus (EBV) infection and is more common in Southeast Asia and parts of South India.

Nasal cavity and sinus cancer develops in the nasal passages and air spaces themselves. The two have different causes, different treatments, and different prognoses. NPC is primarily treated with radiation and chemotherapy — surgery rarely plays a role. Nasal cavity and sinus cancers are primarily treated with surgery + radiation. If you have received a diagnosis, make sure you understand which type you have — the treatment pathways are completely different.

Who Is at Risk of Nasal and Sinus Cancer?

A small number of well-defined exposures account for most nasal and sinus cancers — and several of them are common in Hyderabad's industrial and trade workforce. If you are exposed to any of the following, persistent nasal symptoms should not be brushed off as 'just sinusitis'.

• Tobacco use — smoking and smokeless tobacco are the primary risk factors for nasal cavity squamous cell carcinoma.
• Occupational exposure to wood dust — carpenters, furniture makers, and woodworkers have a significantly elevated risk of adenocarcinoma of the ethmoid sinus; relevant for Hyderabad's furniture and carpentry workforce.
• Occupational exposure to leather dust — cobbling and footwear industry workers; adenocarcinoma of the sinonasal region.
• Exposure to nickel, chromium, and industrial chemicals — metal processing and electroplating workers; relevant to Hyderabad's industrial zones.
• HPV infection — a subset of nasal cavity and sinus SCCs are HPV-positive, with a better prognosis than HPV-negative tumours.
• Chronic sinus inflammation — long-standing, inadequately treated sinusitis is a background risk factor.
• Inverted papilloma — a benign nasal polyp that can undergo malignant transformation; requires complete surgical removal and follow-up.

Diagnosing Nasal and Sinus Cancer at CION

Diagnosis requires a combination of direct visualisation, imaging, and tissue biopsy. CION's diagnostic pathway is thorough, efficient, and aligned with NCCN and ESMO standards.

Nasal Cancer Staging and Survival

Nasal cavity and paranasal sinus cancers are staged using the TNM system. Stage depends on tumour size, extent of local invasion into adjacent structures, and spread to lymph nodes or distant organs. Overall, early-stage cancers have much better outcomes than those detected late — reinforcing the importance of early investigation of suspicious symptoms.

Survival estimates are for squamous cell carcinoma treated at specialist oncology centres. Adenocarcinoma and olfactory neuroblastoma may have different prognoses depending on subtype and stage.

Nasal Cancer Treatment at CION Cancer Clinics

Treatment for nasal and sinus cancer almost always combines surgery and radiation therapy. Chemotherapy is added to radiation for advanced disease. Every patient's plan is reviewed by CION's multidisciplinary tumour board before treatment begins.

Surgery — Removing the Tumour

The primary goal of surgery is to remove the entire tumour with clear margins. The surgical approach depends on the tumour's size, location, and whether it has grown into adjacent structures.

• Endoscopic Endonasal Surgery — the preferred approach for smaller, localised tumours confined to the nasal cavity or accessible sinuses; instruments are passed entirely through the nostrils — no external incisions, no facial scars; the camera guides precise tumour removal while preserving surrounding healthy tissue; recovery is faster than open surgery with equivalent cancer control rates for appropriate tumours.
• Open Surgery (Lateral Rhinotomy, Midfacial Degloving) — for larger tumours that cannot be fully removed endoscopically; involves carefully planned incisions around the nose or inside the mouth to access the tumour; reconstruction of the affected area is planned alongside tumour removal.
• Craniofacial Resection — for advanced tumours that have grown upward into the skull base; involves a combined approach through the face and skull in coordination with neurosurgical input; achieves complete tumour removal while preserving brain structures.
• Maxillectomy — for tumours of the maxillary sinus that have invaded the upper jaw; partial or total removal of the upper jaw (maxilla) with prosthetic or reconstructive rehabilitation.
• Neck Dissection — if the cancer has spread to lymph nodes in the neck, these are removed at the same time.

Radiation Therapy — How IMRT Protects What Matters Most

Radiation therapy after surgery is standard for most nasal and sinus cancers — but this is not straightforward radiation. The nasal cavity sits directly next to the eyes, the optic nerves, the brain, and the spinal cord. Conventional radiation to this area can damage vision and cause serious long-term complications.

This is why IMRT — Intensity-Modulated Radiation Therapy — is the standard technique for nasal and sinus cancer at CION, and why the experience of the radiation oncology team matters enormously. IMRT works by shaping the radiation beam into a precise 3D contour that matches the tumour exactly — like fitting a glove around it. High doses reach the tumour; the surrounding dose falls away sharply, significantly reducing the amount of radiation reaching the eyes, optic nerves, and brain.

Before IMRT became standard, radiation for nasal and sinus cancers carried significant risks of vision loss, dry eye, and optic nerve damage. With IMRT delivered by an experienced team, these risks are substantially reduced. CION's radiation oncology team uses IMRT with daily image guidance (IGRT) to ensure precise targeting on every treatment day.

When the Cancer Is Advanced — Chemotherapy Options

For patients with locally advanced disease, chemotherapy plays two important roles alongside radiation and surgery:

Concurrent Chemotherapy with Radiation

Cisplatin — given weekly or every 3 weeks during radiation — makes cancer cells more sensitive to the radiation beam, improving local control rates. It is used for most patients with Stage III or IVA disease who undergo surgery followed by radiation, or those receiving definitive chemoradiation without surgery.

Neoadjuvant Chemotherapy — Shrinking First, Then Operating

For patients with a tumour that is technically difficult to remove completely — close to the brain, carotid artery, or both orbits — chemotherapy can be given first to shrink it before surgery is attempted. This 'neoadjuvant' approach may convert an unresectable tumour to resectable, giving the patient a chance at curative surgery that would not otherwise have been possible. ESMO guidelines support this approach for selected locally advanced cases. CION's tumour board evaluates every borderline resectable case for neoadjuvant chemotherapy before surgery.

Multidisciplinary Tumour Board — Every Case Reviewed

Nasal and sinus cancer is one of the most anatomically complex cancers to treat. Getting the treatment sequence right — whether to operate first or give chemotherapy first, which surgical approach to use, how to protect the orbits during radiation — requires specialist input from surgical oncology, radiation oncology, and medical oncology together. At CION, every nasal cancer case is reviewed by our multidisciplinary team before any treatment begins:

• Resectability assessment — endoscopic vs open vs craniofacial approach based on MRI and CT.
• Neoadjuvant chemotherapy evaluation for borderline resectable tumours.
• IMRT planning with dose constraints for eyes, optic nerves, and brain.
• HPV testing of biopsy tissue — HPV-positive tumours may have a better prognosis.
• Orbital preservation vs exenteration decision for tumours near the eye socket.
• Reconstructive planning alongside surgical resection.
• Neck dissection evaluation based on imaging and tumour site.
• NCCN protocol alignment across all histological subtypes.
• Digital coordination across all 7 Hyderabad locations.

Why Patients Choose CION for Nasal Cancer Treatment in Hyderabad

Twelve reasons our patients pick CION — endoscopic surgical capability, IMRT protecting eyes and brain, neoadjuvant chemo for borderline cases, and NCCN protocols across 7 Hyderabad locations.

Nasal Cancer Treatment Cost in Hyderabad

The cost of nasal cancer treatment in Hyderabad varies depending on the extent of surgery required and whether radiation and chemotherapy are needed. The reference ranges below are based on current Hyderabad market data. A personalised estimate is provided after your initial oncology consultation at CION.

Costs are indicative. A personalised treatment cost estimate is provided following your initial oncology consultation at CION.

Financial Support Options

• EMI Facility — flexible instalment-based payment options available for all patients.
• Private Health Insurance — CION works with all major TPAs for cashless hospitalisation.

About CION Cancer Clinics

CION Cancer Clinics is India's fastest-growing cancer care network, with over 35 centres across Telangana and Andhra Pradesh. Dedicated exclusively to oncology, CION delivers NABH-accredited, NCCN and ESMO protocol-driven cancer care — bringing world-class treatment closer to patients across the region.

Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your medical condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.

We Walk This Journey with You

Tumour board for every patient. Transparent costs. Decisions for healing, not billing.